hightuberculosi
tb
burden
countri
locat
subsaharan
africa
examin
frequenc
human
leukocyt
antigen
hla
allel
follow
recombin
express
frequent
hlaa
allel
ie
hlaa
hlaa
studi
differ
mycobacteri
peptid
present
tcell
recognit
screen
peptid
librari
peptid
overlap
bind
affin
offrat
mycobacterium
tuberculosisassoci
antigen
identifi
three
peptid
consider
bind
hlaa
contrast
peptid
bound
hlaa
reflect
mark
differ
bind
prefer
two
allel
toler
promiscu
peptidebind
pattern
accommod
select
peptid
repertoir
subsequ
analysi
affin
offrat
bind
peptid
reveal
strong
affin
nm
moder
offrat
min
h
allel
tuberculosi
tb
major
worldwid
problem
approxim
million
individu
newli
infect
million
death
occur
everi
year
highest
tb
incid
found
subsaharan
africa
southeast
asia
call
better
understand
immun
respons
direct
mycobacterium
tuberculosi
blood
sampl
obtain
individu
african
descent
may
aid
develop
new
better
diagnost
well
identif
biomark
help
monitor
novel
tb
vaccin
candid
sinc
current
larg
costli
phase
ii
iii
clinic
trial
defin
effect
vaccin
african
countri
high
tb
burden
dissect
biolog
major
histocompat
complex
mhc
peptid
present
contribut
better
profil
success
immun
respons
ie
respons
individu
expos
yet
appear
protect
tb
less
success
respons
individu
latent
activ
tb
mani
part
immun
system
play
import
role
tuberculosisdirect
respons
adapt
antim
tuberculosi
immun
respons
depend
present
diseaseassoci
immunogen
peptid
via
mhc
molecul
tcell
receptor
tcr
cell
tcell
recognit
peptid
deriv
protein
presenc
costimulatori
signal
lead
tcell
activ
prolifer
identif
novel
antigen
peptid
recogn
cell
present
via
trimer
heavychain
microglobulin
peptidemhc
class
complex
therefor
great
valu
better
understand
cytotox
tlymphocyt
ctl
mediat
antim
tuberculosi
immun
respons
mhc
class
polymorph
molecul
human
bodi
differ
allel
identifi
human
date
major
polymorph
lie
within
exon
code
peptidebind
pocket
mhc
class
molecul
allel
associ
differ
peptidebind
prefer
summar
peptidebind
motif
allel
distribut
frequenc
differ
consider
ethnic
popul
therefor
effort
increas
knowledg
diseaserel
epitop
associ
populationrelev
differ
mhc
class
molecul
understand
cellular
immun
respons
individu
differ
ethnic
background
need
includ
frequent
allel
individu
african
descent
human
leukocyt
antigen
hla
famili
one
frequent
allel
famili
individu
african
background
consist
allel
common
hlaa
hlaa
individu
mhc
class
allel
may
impact
diseas
suscept
differ
may
guid
vaccin
effort
describ
antigenspecif
melanoma
antigen
recogn
cell
immun
patient
melanoma
peptid
vaccin
elicit
cellular
immun
respons
hlaa
individu
hlaa
although
amino
acid
situat
peptidebind
pocket
differenti
hlaa
hlaa
prefer
peptid
select
observ
mhc
class
ibind
peptid
identifi
hlaa
peptid
origin
vaccinia
viru
hlaa
eg
peptid
origin
plasmodium
falciparum
sever
acut
respiratori
syndromeassoci
coronaviru
regard
tb
four
peptid
present
hlaa
identifi
rpkpd
ysam
rvrqawdtl
hypothet
protein
ra
wgrrlmi
antigen
rgrigrtyl
glucos
dehydratas
thu
far
tuberculosi
epitop
identifi
hlaa
part
due
lack
detail
knowledg
concern
peptidebind
motif
inabl
perform
affin
offrat
analys
chose
tuberculosi
protein
paradigm
sinc
compon
sever
novel
candid
vaccin
tb
repres
earli
secret
virul
factor
present
virul
tuberculosi
strain
bovi
bacillu
bcg
vaccin
strain
use
recombin
mhc
molecul
screen
peptid
librari
bind
affin
offrat
use
african
mhc
class
allel
hlaa
hlaa
novel
bind
peptid
character
affin
offrat
studi
subsequ
tetram
construct
use
visual
ex
vivo
antigenspecif
cell
patient
acut
pulmonari
tb
clone
bacteri
express
vector
contain
nucleotid
sequenc
solubl
part
heavi
chain
mhc
class
allel
hlaa
lightchain
microglobulin
obtain
beckman
coulter
san
diego
ca
gene
hlaa
obtain
alter
hlaa
sequenc
use
sitedirect
mutagenesi
kit
stratagen
la
jolla
ca
mutat
made
creat
hlaa
recombin
protein
recombin
mhc
class
molecul
produc
describ
briefli
heavi
light
chain
produc
inclus
bodi
escherichia
coli
pli
invitrogen
carlsbad
ca
solubil
urea
buffer
ph
sigmaaldrich
sweden
ab
stockholm
sweden
mhc
class
heavi
light
chain
fold
allelespecif
peptid
jpt
peptid
technolog
gmbh
berlin
germani
day
mm
mm
mm
edta
buffer
ph
peptid
ktkdivngl
factincap
protein
beta
kiqnf
rvyy
human
immunodefici
viru
hiv
integras
use
fold
mhc
class
ipeptid
monom
concentr
use
stir
cell
devic
millipor
billerica
biotinyl
use
enzym
bira
avid
aurora
il
biotinyl
monom
concentr
affin
purifi
use
avidin
column
thermo
fisher
scientif
rockford
il
epitop
screen
assay
coat
plate
ninetysixwel
plate
greinerbio
one
gmbh
frickenhausen
germani
first
coat
biotinyl
bovin
serum
albumin
bsa
follow
avidin
beckman
coulter
plate
block
bsa
coat
gml
biotinyl
monom
ii
bind
assay
nonam
peptid
overlap
amino
acid
aa
cover
whole
sequenc
total
peptid
synthes
jpt
peptid
technolog
gmbh
peptidebind
affin
offrat
experi
perform
duplic
mhc
monomerco
plate
report
monomerco
plate
strip
placehold
peptid
leav
heavi
chain
free
associ
candid
peptid
addit
microglobulin
peptid
bind
detect
fluoresc
h
incub
conform
antibodi
ab
igm
clone
one
lambda
inc
canoga
park
ca
fluorescencelabel
secondari
antibodi
goat
antimous
igmalexa
fluor
clone
invitrogen
bind
candid
peptid
compar
bind
appropri
control
peptid
ktkdivngl
kiqnf
rvyy
detail
analysi
bind
characterist
individu
peptid
perform
use
affin
offrat
assay
iii
offrat
assay
stabil
trimer
heavychain
microglobulinpeptid
complex
analyz
incub
refold
mhc
molecul
eight
differ
time
h
h
h
h
h
h
h
h
offrat
express
halflif
valu
defin
time
point
initi
peptid
concentr
dissoci
hlapeptid
molecul
complex
iv
affin
assay
affin
measur
incub
mhc
class
allel
differ
concentr
individu
peptid
overnight
calcul
peptid
quantiti
need
achiev
bind
satur
effect
dose
ed
valu
v
calcul
valu
peptid
bind
affin
offrat
calcul
use
itopia
system
softwar
sigmoid
doserespons
curv
gener
use
prism
version
softwar
graphpad
cellular
analysi
total
healthi
individu
cape
town
south
africa
volunt
particip
studi
determin
mhc
frequenc
peripher
blood
mononuclear
cell
pbmc
individu
twodigit
mhc
class
type
univers
blood
bank
univers
mainz
hlaa
sampl
select
subsequ
fourdigit
type
blood
bank
karolinska
univers
hospit
hudding
sweden
pbmc
patient
diagnos
activ
pulmonari
tuberculosi
obtain
univers
pretoria
pretoria
south
africa
institut
review
board
approv
inform
consent
document
refer
faculti
health
scienc
univers
pretoria
south
africa
ethic
committe
stockholm
sweden
refer
number
pbmc
hla
type
use
sequencespecif
primer
ssp
type
kit
one
lambda
inc
four
specimen
posit
hlaa
four
posit
hlaa
identifi
mhc
class
ityp
pbmc
sampl
posit
mhcbind
peptid
use
construct
recombin
mhc
class
molecul
molecul
subsequ
use
prepar
tetram
previous
describ
tetram
ktkdivngl
load
selfepitop
deriv
factincap
protein
beta
epitop
kiqnfr
vyy
hiv
type
integras
also
construct
control
reagent
individu
found
react
hlaa
complex
cell
data
shown
reagent
therefor
use
positivecontrol
tetram
hiv
integras
epitop
serv
neg
tetram
mhc
class
monom
contain
select
epitop
incub
togeth
fluorescencelabel
streptavidin
ratio
room
temperatur
min
follow
six
tuberculosi
tetram
construct
label
streptavidinphycoerythrin
pe
streptavidinallophycocyanin
apc
qimynypam
pe
lvrayham
pe
qimynypam
pe
qimynypam
apc
imynypaml
pe
amedlvray
pe
cellular
analys
perform
use
fluorescenceactiv
cell
sorter
gallio
flow
cytomet
beckman
coulter
tetramerposit
event
identifi
lymphocyt
popul
use
follow
ab
peridinin
chlorophyl
protein
clone
becton
dickinson
franklin
lake
nj
alexa
fluor
clone
pacif
blue
clone
beckman
coulter
cell
compart
exclud
enumer
tetramerposit
event
subsequ
analys
natur
tetramerposit
event
perform
use
follow
ab
ta
ble
supplement
materi
specimen
subsequ
perform
fourdigit
type
deciph
natur
actual
allel
follow
percentag
identifi
hlaa
cohort
hlaa
also
found
frequent
mhc
class
allel
individu
pulmonari
tb
unpublish
data
identif
mhcbind
peptid
overlap
peptid
test
bind
two
hla
molecul
hlaa
hlaa
peptid
bind
greater
allelespecif
positivecontrol
peptid
consid
candid
peptid
peptidebind
pattern
differ
two
allel
sinc
peptid
identifi
binder
hlaa
identifi
binder
hlaa
fig
tabl
hlaa
exhibit
much
restrict
peptidebind
pattern
hlaa
three
hlaa
peptid
qimynypam
imynypaml
lvray
ham
exhibit
high
mhcbind
valu
rang
valu
positivecontrol
peptid
peptid
bind
hlaa
also
identifi
bind
hlaa
segreg
hlaa
peptid
two
differ
group
high
binder
bind
level
bind
posit
control
intermedi
binder
bind
level
bind
posit
control
first
group
identifi
peptid
amedlvray
dmagyagtl
show
even
better
bind
posit
control
posit
control
respect
tabl
second
group
identifi
six
addit
peptid
posit
bind
peptid
allel
found
throughout
whole
amino
acid
sequenc
affin
offrat
studi
affin
peptid
defin
bind
strength
nomin
peptid
tabl
z
axi
indic
percent
bind
respect
peptid
compar
allelespecif
positivecontrol
peptid
ktkdivngl
kiqnfrvyy
red
bind
hlaa
blue
bind
hlaa
mhc
molecul
hlaa
affin
rang
hlaa
rang
nm
gener
affin
higher
peptid
bind
hlaa
peptid
bind
hlaa
fig
tabl
also
found
true
concern
three
peptid
bound
hlaa
hlaa
exhibit
higher
affin
toward
hlaa
hlaa
versu
nm
nm
hlaa
respect
tabl
dissoci
rate
moder
fast
vari
min
h
hlaa
allel
hlaa
slightli
wider
rang
offrat
peptid
sqimynypa
dissoci
rapidli
min
peptid
imynypaml
valu
bind
h
gener
differ
concern
dissoci
rate
two
allel
could
identifi
fig
tabl
cellular
analysi
select
epitop
construct
tetramer
mhc
class
ipeptid
complex
evalu
whether
candid
peptid
serv
target
epitop
cell
patient
pulmonari
tb
peptid
chosen
basi
high
affin
valu
slow
dissoci
rate
import
paramet
tetram
stabil
sinc
peptid
qimynypam
bound
rel
stabli
hlaa
hlaa
construct
two
differ
tetram
present
ident
peptid
tetram
use
stain
epitopespecif
cell
hlaa
patient
abl
identifi
antigenspecif
cell
bind
entir
panel
epitop
load
onto
novel
tetram
molecul
present
current
report
epitop
lvrayham
present
show
strongest
tcell
recognit
follow
epitop
qimynypam
present
antigenspecif
tcell
frequenc
cell
tabl
could
identifi
gener
differ
frequenc
mhcpeptidespecif
cell
pbmc
patient
type
hlaa
concern
recognit
qimynypam
lvrayham
mhcpeptid
complex
peptid
present
allel
true
regard
pbmc
hlaa
patient
recogn
tetram
equal
level
tabl
next
address
question
whether
peptid
qimynypam
present
hlaa
hlaa
recogn
differ
cell
hlaa
hlaa
patient
one
way
address
question
ex
vivo
sort
mhctetram
antigenspecif
cell
follow
tcr
analysi
yet
frequenc
tetramerreact
cell
low
allow
approach
use
use
altern
way
test
whether
cell
recogn
hlaa
hlaa
tetram
complex
exhibit
immun
phenotyp
use
marker
major
total
tcell
popul
pbmc
obtain
patient
pulmonari
tb
exhibit
peripher
memori
effector
phenotyp
contrast
tuberculosi
antigenspecif
cell
defin
tetram
stain
show
differ
phenotyp
higher
percentag
precursor
cell
central
memori
cell
termin
differenti
cell
fig
observ
signific
differ
concern
phenotyp
qimynypaml
epitopespecif
cell
mhc
class
irestrict
molecul
ie
hlaa
hlaa
fig
marker
analysi
follow
examin
receptor
express
total
cell
compar
tetramerposit
cell
fig
express
receptor
appear
crucial
memori
tcell
gener
express
reflect
tcell
degranul
major
cell
stain
neg
yet
posit
degranul
marker
differ
tetramerreact
cell
show
strong
simultan
express
receptor
express
analysi
show
differ
qimynypam
qimynypam
specif
tcell
interact
fig
tuberculosi
particularli
conjunct
hiv
infect
impos
global
health
threat
certainli
prime
target
vaccin
develop
address
need
develop
tool
enabl
molecular
cellular
studi
mhc
class
ipeptid
interact
tcell
recognit
pbmc
individu
african
descent
produc
tetram
tool
base
hlaa
hlaa
allel
common
africa
identifi
high
preval
two
allel
subsequ
proceed
produc
recombin
protein
allow
us
identifi
mhc
class
ibind
peptid
tuberculosi
target
protein
report
induc
tcell
respons
upon
bcg
vaccin
upon
natur
infect
respons
vaccin
differ
hlaa
hlaa
constitut
four
amino
acid
three
amino
acid
posit
situat
helic
form
side
peptidebind
cleft
may
therefor
directli
affect
peptid
bind
affin
offrat
sinc
amino
acid
substitut
lead
chang
size
electr
charg
polar
amino
acid
situat
b
e
f
pocket
respect
previous
report
import
peptid
interact
form
contact
amino
acid
number
bind
peptid
last
differenti
amino
acid
posit
situat
adjac
peptidebind
cleft
protrud
side
chain
could
potenti
affect
tcell
recognit
biochem
featur
hlaa
concern
peptid
present
still
unsolv
sever
conflict
report
exist
regard
peptidebind
specif
one
report
suggest
peptidebind
prefer
reflect
peptidebind
motif
x
yf
xxxxxxl
lamberth
et
al
report
anoth
motif
hlaa
ie
xx
xxxxx
kvr
studi
indic
amino
acid
central
anchor
point
concern
peptid
bind
differ
studi
suggest
amino
acid
residu
may
import
anchor
residu
peptidemhc
interact
studi
confirm
motif
sinc
identifi
three
posit
bind
peptid
allel
indic
prefer
tyrosin
residu
ctermin
posit
prefer
hydrophob
aromat
amino
acid
posit
similar
motif
describ
ctermin
posit
aromat
hydrophob
amino
acid
import
part
peptid
bind
propos
sidney
et
al
result
agre
part
find
ie
hlaa
peptid
evalu
studi
exhibit
aromat
hydrophob
small
uncharg
amino
acid
ctermin
posit
identifi
differ
amino
acid
posit
hlaa
peptid
amino
acid
posit
also
show
great
variat
indic
hlaa
appear
util
multipl
secondari
anchor
residu
cand
ntermin
region
may
therefor
show
promiscu
bind
motif
may
explain
larg
number
posit
hlaa
peptid
identifi
studi
also
underlin
use
silico
predict
program
use
common
bind
motif
allel
hlaa
hlaa
may
underestim
number
candid
bind
peptid
actual
measur
mhc
class
ipeptid
interact
appear
necessari
object
identifi
target
peptid
protein
found
major
differ
two
hlaa
allel
restrict
peptidebind
profil
hlaa
compar
profil
hlaa
hlaa
previous
describ
allel
broad
bind
pattern
contrast
hlaa
propos
behav
similarli
hlaa
allel
restrict
peptidebind
pattern
yet
direct
comparison
perform
knowledg
like
amino
acid
substitut
differ
hlaa
hlaa
lead
profound
differ
structur
peptidebind
cleft
eg
introduct
big
bulki
tryptophan
posit
hlaa
posit
contribut
shape
e
pocket
might
affect
abil
accommod
big
amino
acid
ctermin
end
fact
identifi
hlaa
peptid
studi
exhibit
rel
small
amino
acid
posit
substitut
lead
chang
electr
charg
neg
charg
hlaa
posit
charg
hlaa
may
reason
one
peptidebind
motif
show
prefer
posit
charg
amino
acid
c
terminu
although
could
denitrifi
peptid
characterist
confirm
theori
await
crystal
structur
protein
avail
time
summari
substanti
differ
hlaa
hlaa
underlin
valu
accur
fourdigit
type
hlaa
famili
context
suscept
protect
diseas
instanc
hlaa
identifi
one
risk
factor
develop
cytomegaloviru
cmv
diseas
allogen
hematopoiet
stem
cell
transplant
clear
associ
due
instead
limit
capac
hlaa
present
cmv
peptid
cell
mani
peptid
identifi
good
binder
hlaa
allel
promiscu
peptid
previous
describ
binder
one
sever
mhc
class
allel
eg
msqimynyp
offrat
graph
show
individu
peptid
offrat
hour
compar
allelespecif
posit
control
valu
calcul
use
sigmoid
curv
fit
curv
fit
use
graphpad
prism
softwar
allel
identifi
epitopespecif
cell
epitop
imynypaml
present
four
differ
mhc
molecul
includ
encod
african
allel
hlaa
import
dissect
multiallel
focu
certain
target
peptid
benefici
rather
detriment
context
immun
protect
infecti
diseas
individu
certain
mhc
class
genotyp
would
allow
differ
mhc
molecul
present
peptid
simultan
cell
time
frame
describ
bind
certain
peptid
speci
select
mhc
class
molecul
biolog
import
sinc
reflect
time
frame
epitop
would
avail
tcell
prime
target
recognit
effector
phase
immun
respons
studi
use
concept
affin
dissoci
time
previou
studi
use
recombin
mhc
molecul
shown
mhc
allel
affin
ed
lie
nm
true
peptid
analyz
hlaa
yet
identifi
peptid
even
higher
affin
ed
nm
previou
report
suggest
correl
high
affin
domin
tcell
respons
howev
distinct
yet
low
frequenc
tetramerreact
cell
suggest
domin
recognit
context
acut
pulmonari
tb
frequenc
targetspecif
cell
similar
antigenspecif
cell
cancer
low
frequenc
peptidereact
cell
peripher
circul
preclud
clinic
efficaci
mutual
exclus
hlaa
hlaa
cell
may
show
differ
frequenc
initi
antim
tuberculosi
therapi
immun
reconstitut
eg
tcr
zetachain
recoveri
tcell
redistribut
tetramerguid
identif
tuberculosisdirect
tcell
respons
may
critic
acut
pulmonari
tb
often
associ
tcell
anergi
dysfunct
cytokin
product
may
also
help
trace
tuberculosisreact
cell
pbmc
patient
hivm
tuberculosi
coinfect
sinc
less
cellsl
blood
associ
falseneg
result
interferon
ifn
base
immunolog
diagnost
test
system
aim
current
studi
map
detail
tcell
respons
individu
differ
clinic
present
tb
determin
hlaa
peptid
recogn
cell
patient
tb
hlaa
peptid
recogn
cell
obtain
hlaa
individu
entir
panel
mhc
class
peptid
complex
recogn
antigenspecif
cell
pbmc
patient
pulmonari
tb
irrespect
hlaa
hlaa
background
observ
differ
previou
studi
crossrecognit
observ
use
hiv
peptid
cell
hlaa
hlaa
subject
defin
gamma
ifn
enzymelink
immunospot
assay
may
reflect
either
natur
hiv
peptid
may
bind
picki
hlaa
allel
mutual
exclus
lack
ifn
product
hlaa
cell
detect
gener
differ
tcell
recognit
appli
tetram
peptid
use
pbmc
patient
also
true
use
peptid
qimynypam
bound
either
hlaa
hlaa
phenotyp
defin
express
tetramerposit
cell
appear
similar
cell
recogn
tcell
epitop
major
cell
exhibit
precursor
compart
profil
ie
express
find
line
previou
find
regard
marker
analysi
tetramerspecif
cell
recogn
anoth
tuberculosi
antigen
ie
yet
differ
find
studi
show
major
antigenspecif
cell
tuberculosi
may
resid
memori
compart
termin
differenti
effector
popul
compart
possibl
explan
high
number
antigenspecif
precursor
cell
studi
may
increas
lymphopoiesi
patient
tb
mutual
exclus
could
also
due
recycl
termin
differenti
cell
precursor
cell
ie
cell
revert
quiescent
state
indistinguish
precursor
cell
basi
express
truli
may
therefor
also
show
differ
telomer
length
exhibit
differ
tcell
receptor
excis
cycl
content
phenotyp
epitopereact
cell
specif
epitop
qimynypam
present
either
hlaa
hlaa
appear
similar
influenc
restrict
molecul
fig
also
true
express
receptor
cytotox
marker
fig
differ
singl
amino
acid
hlaa
hlaa
posit
protrud
peptidebind
pocket
may
therefor
possibl
tcell
popul
recogn
ident
peptid
bound
either
hlaa
hlaa
howev
would
requir
studi
examin
greater
detail
tcell
frequenc
hlaa
cell
react
broader
array
hlaa
peptid
use
tetram
molecul
sinc
certain
peptid
speci
may
present
tcell
repertoir
hlaa
individu
tcr
may
recogn
target
peptid
irrespect
mhc
present
allel
describ
mutual
exclus
differ
peptidebind
groov
hlaa
hlaa
might
influenc
conform
bind
peptid
therebi
alter
surfac
expos
tcr
influenc
tcell
recognit
differ
exposur
peptid
backbon
respond
cell
may
affect
tcell
recognit
subsequ
tcell
effector
function
flexibl
tcr
may
even
contribut
mhc
class
ipeptid
recognit
pattern
tcr
famili
may
even
allow
effect
recognit
point
mutat
target
peptid
contribut
immun
protect
summari
use
recombin
mhc
class
molecul
identifi
novel
target
peptid
hlaa
candid
peptid
hlaa
tuberculosi
protein
describ
mark
differ
concern
bind
characterist
restrict
bind
pattern
hlaa
compar
hlaa
construct
mhc
class
ipeptid
tetram
complex
visual
antigenspecif
cell
peripher
blood
patient
pulmonari
tb
avail
reagent
aid
work
intervent
strategi
molecular
design
pathogen
ie
tuberculosi
hiv
preval
african
popul
